Healthcare provider profile · identity verified

Robert Paul Matsko, D.O.

Family Practice · ENOLA, PA · NPI 1104819283

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	409	128
Lisinopril	Lisinopril	375	109
Rosuvastatin Calcium	Rosuvastatin Calcium	301	96
Amlodipine Besylate	Amlodipine Besylate	241	77
Levothyroxine Sodium	Levothyroxine Sodium	233	64
Metoprolol Succinate	Metoprolol Succinate	189	56
Omeprazole	Omeprazole	187	53
Losartan Potassium	Losartan Potassium	178	57
Simvastatin	Simvastatin	163	45
Lorazepam	Lorazepam	150	37
Pantoprazole Sodium	Pantoprazole Sodium	129	37
Metformin Hcl Er	Metformin Hcl	125	40
Hydrochlorothiazide	Hydrochlorothiazide	121	41
Metformin Hcl	Metformin Hcl	117	36
Escitalopram Oxalate	Escitalopram Oxalate	110	35
Glimepiride	Glimepiride	101	25
Gabapentin	Gabapentin	98	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	23
Meloxicam	Meloxicam	80	19
Tamsulosin Hcl	Tamsulosin Hcl	80	29
Eliquis	Apixaban	79	19
Sertraline Hcl	Sertraline Hcl	78	25
Albuterol Sulfate Hfa	Albuterol Sulfate	77	29
Jardiance	Empagliflozin	77	20
Furosemide	Furosemide	76	26
Metoprolol Tartrate	Metoprolol Tartrate	73	25
Potassium Chloride	Potassium Chloride	69	17
Tramadol Hcl	Tramadol Hcl	67	suppressed
Allopurinol	Allopurinol	62	20
Clopidogrel	Clopidogrel Bisulfate	59	16
Citalopram Hbr	Citalopram Hydrobromide	58	17
Fluticasone Propionate	Fluticasone Propionate	57	20
Montelukast Sodium	Montelukast Sodium	55	18
Zolpidem Tartrate	Zolpidem Tartrate	53	suppressed
Ezetimibe	Ezetimibe	51	16
Pioglitazone Hcl	Pioglitazone Hcl	46	15
Duloxetine Hcl	Duloxetine Hcl	45	12
Nifedipine Er	Nifedipine	45	12
Fluoxetine Hcl	Fluoxetine Hcl	44	12
Ondansetron Hcl	Ondansetron Hcl	42	suppressed
Trazodone Hcl	Trazodone Hcl	42	17
Januvia	Sitagliptin Phosphate	41	suppressed
Ozempic	Semaglutide	40	suppressed
Bupropion Xl	Bupropion Hcl	39	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	15
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	suppressed
Azithromycin	Azithromycin	33	31
Famotidine	Famotidine	33	11
Clonazepam	Clonazepam	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Amoxicillin	Amoxicillin	31	15
Buspirone Hcl	Buspirone Hcl	31	suppressed
Finasteride	Finasteride	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Atenolol	Atenolol	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Carvedilol	Carvedilol	27	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	18
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Methylprednisolone	Methylprednisolone	22	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Valsartan	Valsartan	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Cephalexin	Cephalexin	13	13
Clonidine Hcl	Clonidine Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Nystatin	Nystatin	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	12
Dutasteride	Dutasteride	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Cryselle	Norgestrel-Ethinyl Estradiol	11	suppressed
Glipizide	Glipizide	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Linzess	Linaclotide	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Prednisone	Prednisone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error